<DOC>
	<DOCNO>NCT00190528</DOCNO>
	<brief_summary>To investigate clinical benefit neoadjuvant chemotherapy bulky stage I/II cervical cancer</brief_summary>
	<brief_title>A Trial Neoadjuvant Chemotherapy + Surgery v . Surgery Bulky Stage I/II Cervical Cancer</brief_title>
	<detailed_description>We design randomize study investigate clinical benefit neoadjuvant chemotherapy bulky stage I/II cervical cancer . Patients FIGO stage I/II bulky disease randomize either neoadjuvant chemotherapy ( BOMP : Cisplatin 14mg/m2 day 1-5 , Bleomycin 7mg day 1-5 , Mitomycin 7mg/m2 day 5 , Vincristine 0.7mg/m2 day every 21 day 2-4 cycle follow radical hysterectomy radical hysterectomy alone . The primary endpoint overall survival secondary endpoint progression-free survival , complication surgery , completeness radical hysterectomy , omission postsurgical irradiation , completeness postsurgical irradiation , response rate , adverse event . A total 200 patient ( 100 per treatment arm ) plan accrue study within 5.5 year .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>1 . Untreated cervical cancer 2 . Pathologically diagnose squamous carcinoma 3 . FIGO stage Ib2 , IIa ( &gt; 4cm ) , IIb 4 . Measurable lesion 5 . Possible radical hysterectomy 6 . Age : 20 70 year 7 . PS : 0 1 8 . WBC &gt; 3,000/mm3 , Hb &gt; 9.0g/dl , Platelet &gt; 100,000 /mm3 , SGOT/SGPT &lt; 60 IU/L , TBil &lt; 1.5 mg/dL , Cr &lt; 1.2 mg/dL , PaO2 &gt; 80 torr , normal ECG 9 . Written inform consent 1 . Patients evidence cancer present within last 5 year exception carcinoma situ intramucosal cancer curable local therapy 2 . Women pregnancy breastfeed 3 . Patients psychiatric illness 4 . Patients active infection 5 . Patients uncontrolled diabetes uncontrolled hypertension 6 . Patients positive HBs 7 . Patients heart failure , unstable angina , myocardial infarction within past 6 month 8 . Patients interstitial pneumonitis pulmonary fibrosis 9 . Patients unable undergo radical hysterectomy complication excessive obesity , liver cirrhosis , bleeding tendency</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>drug therapy</keyword>
	<keyword>cisplatin</keyword>
	<keyword>bleomycin</keyword>
	<keyword>mitomycin</keyword>
	<keyword>vincristine</keyword>
</DOC>